Skip to main content
Premium Trial:

Request an Annual Quote

Collette Saccomannoas, Bernardus Machielse, Frank Malinoski, Christine Dingivan, John Lewis, Herren Wu, Alan Taggart, Ruedi Aebersold, Jan Ellenberg, Ulf Landegren, Lee Hood, Eli Zangvil, Margaret Chan, Stephen Straus, Elias Zerhouni, Ruth Kischstein

Gene Express announced the appointment of Colette Saccomannoas as director of business development. She was formerly a program manager at ArisGlobal, where her clients included pharmaceutical, medical device, and biotechnology companies, as well as clinical research organizations and research institutions. Soccomannoas has also held executive-level posts in Covance, Vysis (now Abbott Molecular) and the Clinical Diagnostics Group of Bio-Rad Laboratories.

MedImmune announced several senior executive-level promotions, including: Bernardus Machielse to executive vice president of operations; Frank Malinoski to senior vice president of medical affairs; Christine Dingivan to senior vice president of clinical development and operations; John Lewis to vice president of global engineering capital projects; and Herren Wu to vice president of antibody discovery and protein engineering.
Also, Alan Taggart joined MedImmune in the newly created position of vice president of government project management. Taggart joined the company in September from Pittiglio Rabin Todd & McGrath, where he was a management consultant.

The European Molecular Biology Organization has announced new members:
Ruedi Aebersold of the Institute of Molecular Systems Biology in Zurich, Switzerland; Jan Ellenberg of the European Microbiology Laboratory in Heidelberg, Germany; Lee Hood of the Institute for Systems Biology in Seattle; and Ulf Landegren of the Department of Genetics and Pathology at Uppsala University, Sweden.

Metabolon has named Dan Stevens as its new marketing director. He previously worked at SGI, where he served as director of life sciences and business development.

Cellumen has appointed Lee Hood to its scientific advisory board, the company said last week. Hood is president of the Institute for Systems Biology in Seattle.

Compugen has appointed Eli Zangvil to the position of vice president of business development, where he will focus on strategic alliances and other development activities.
Zangvil comes to Compugen from the Israeli company UltraShape, where he was COO, and before that from the Israeli Defense Force, where he was head of medical services.
Compugen said Zangvil will help direct the company’s therapeutics, diagnostic biomarkers and research discovery segments, as well as work with the company’s corporate development strategies.

The World Health Organization has named Margaret Chan its next director-general.
Chan had been WHO’s assistant director-general for communicable diseases, a representative for the group’s director-general of pandemic influenza, and as director of health for Hong Kong.
While in Hong Kong, Chan led the response to outbreaks of SARS and avian influenza.

Stephen Straus has stepped down from his post as director of the National Center for Complementary and Alternative Medicine for health reasons, the NCCAM said this week.
Straus has become senior advisor to NIH Director Elias Zerhouni.
Ruth Kischstein, former director of National Institute of General Medical Sciences and former acting director of the NIH, has taken over as acting director of the NCCAM.

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.